FDA Enforcement Class II Terminated

Proteus 235 The PTS is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

Recall: Z-2173-2018 · Reported June 20, 2018

Enforcement

Recall Number
Z-2173-2018
Event ID
80222
Classification
Class II
Status
Terminated
Product Type
Devices
Firm
Ion Beam Applications S.A.
Voluntary / Mandated
Voluntary: Firm initiated
Initial Notification
Letter
Report Date
June 20, 2018
Initiation Date
August 7, 2016
Classification Date
June 12, 2018
Termination Date
March 25, 2020
Address
Chemin du Cyclotron, 3, N/A, Louvain La Neuve, N/A, N/A, Belgium

Description

Proteus 235 The PTS is a medical device designed to produce and deliver a proton beam for the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation. The PTS may include a fixed small beam treatment room dedicated to the treatment of patients with localized tumors and other conditions susceptible to treatment by radiation localized to the head and neck.

Reason

IBA is recalling to provide information through a Safety Notice to reduce risk for maintenance technicians during ion source replacement.

Code Info

Code/Serial Numbers: PAT.000, PAT.003, PAT.006, PAT.107, PAT.108, PAT.109, PAT.110, PAT.111, PAT.112, PAT.113, PAT.114, PAT.115, SAT.116, SAT.117, SAT.119, SAT.120, SAT.122, SAT.123, SAT.126.

Distribution

Units were distributed in the USA, Korea, Germany, France, Czech Republic, Italy, Poland, and Sweden. Each country's national Competent Authorities have been informed.

Quantity

19 units